Cardiff Lexington Corp

Cardiff Lexington's capital structure is highly leveraged, with a debt-to-equity ratio of 6.08, indicating significant reliance on debt financing. The company's liquidity position is weak, as evidenced by a current ratio of 0.87, suggesting that it may struggle to meet short-term obligations without external financing. Free cash flow is negative at -$6.82 million, and operating cash flow is also negative at -$2.85 million, further highlighting the company's cash flow challenges. Profitability metrics are concerning, with a return on equity of -179.24% and a return on assets of -18.93%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The net loss of $5.51 million contrasts sharply with the gross profit of $7.21 million, suggesting high operating expenses or other non-operating costs are eroding profitability. The company's revenue is concentrated in its healthcare segment, which provides diagnostic and surgical services for musculoskeletal injuries and disorders. The real estate segment, while contributing to the company's asset base, does not appear to be a significant source of revenue. The real estate holdings include five acres zoned for medium-density residential development, six acres for high-density residential, and twelve acres zoned for agriculture, but the financial contribution of this segment is not disclosed. Growth trajectory is uncertain, with no clear indication of revenue expansion in the near term. The company's outlook for the current fiscal year does not include a positive revenue delta, and there is no disclosed plan for scaling operations or entering new markets. The lack of a clear growth strategy, combined with the company's financial challenges, raises concerns about its long-term viability. Risk factors include liquidity constraints and the potential for further debt financing, which could lead to increased financial leverage. The company's dilution potential is currently low, but the risk of future dilution remains if the company needs to raise additional capital. The risk assessment indicates a medium liquidity risk, with key flags pointing to negative net cash after subtracting total debt. Recent events include the continued operation of Nova Ortho and Spine, LLC, which provides diagnostic and surgical services, and the maintenance of real estate holdings through Edge View Properties, Inc. No significant new developments or strategic initiatives have been disclosed in the latest filings, and there are no recent transcripts or press releases indicating a change in direction or new opportunities.